Molecule to Market is a podcast focused on the pharmaceutical and biotech industries, particularly the outsourcing and supply chain side of drug development. Hosted by Raman
Whitepaper Bridging the Gap to ROI: The Power of Technology Backed by Expertise Writers: John Fitzpatrick, Chief Technology Officer and John Cogan, Chief Operating Officer
Why an AI Enhanced Approach to Pharmacovigilance Case Processing is now Non-negotiable Qinecsa CEO, Adam Sherlock has been featured in Simedics (The Journal of mHealth)
04 April 2022, London – Qinecsa Solutions announced the acquisition of MyMeds&Me Limited (MMM). Qinecsa, a leading provider of pharmacovigilance services and technologies to the
21th March 2024 —Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announce its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology,
15 December 2022, London – Qinecsa Solutions UK Ltd. (Qinecsa) has announced the acquisition of Commonwealth Informatics, Inc. (Commonwealth). Qinecsa, a leading provider of pharmacovigilance
We’re proud to be featured in Applied Clinical Trials’ latest article spotlighting the future of pharmacovigilance: “Harnessing Technology and Adopting Unified Approaches to Optimize Pharmacovigilance
Effective pharmacovigilance demands continuous monitoring of drug safety signals, a critical process that ensures accurate benefit-risk assessment while meeting global regulatory requirements. This paper examines
Written by Martin Holm-Petersen, Chief Strategy Officer Preamble This will be the first in a series of articles about the application of artificial intelligence (AI) and advanced
We are thrilled to share that Qinecsa’s Chief Strategy Officer, Martin Holm-Petersen, has been featured in IPI Journal’s article on the future of technology-led innovation
